In July 2025, the European Competition Commission imposed a EUR 489,000 fine on Alchem International Pvt. Ltd. and its Hong Kong subsidiary for their involvement in a pharmaceutical cartel involving the active ingredient used...more
8/7/2025
/ Anti-Competitive ,
Antitrust Violations ,
Cartels ,
Civil Monetary Penalty ,
Competition Authorities ,
Enforcement Actions ,
Enforcement Priorities ,
EU ,
European Commission ,
Israel ,
Manufacturers ,
Pharmaceutical Industry ,
Subsidiaries ,
Supply Chain
The Israel Competition Authority’s Director General recently announced that, subject to a hearing, she intends to rule that Strauss and Wyler Farm violated the Economic Competition Law and implemented a merger that could harm...more
The Israel Competition Authority (ICA) recently published a revised public statement on the regulation of resale price maintenance (RPM) arrangements. Under such arrangements, an entity in the goods supply chain (typically, a...more
2022 was an intensive year in competition law. Material issues to the competition agenda were addressed in precedential determinations and rulings by the Competition Authority and by Israeli courts. These issues include...more
1/26/2023
/ Antitrust Litigation ,
Antitrust Provisions ,
Antitrust Violations ,
Competition ,
Competition Authorities ,
Corporate Fines ,
Criminal Liability ,
Excessive Pricing ,
Mergers ,
Monopolization ,
Premerger Notifications ,
Public Agencies ,
Resale Pricing ,
Supply Chain ,
Supreme Court of Israel
The Competition Director General has issued a precedent-setting determination against the pharmaceutical marketing company MBI Pharma Ltd. (MBI). The Director General determined that MBI abused its monopolistic position and...more
1/23/2023
/ Anti-Competitive ,
Competition Authorities ,
Corporate Fines ,
Drug Pricing ,
Enforcement Actions ,
Excessive Pricing ,
Israel ,
Ministry of Health ,
Monopolization ,
Pharmaceutical Industry ,
Prescription Drugs ,
Unfair Competition